Recent Posts
- MicroRNA-Mediated Metastasis Suppression
- A New Explanation Of ‘Asian Paradox’
- Toward Bold New Anti-cancer Medicines
- Celsion And Yakult Honsha Announce Treatment Of First Patient In Japan In Celsion’s Global Phase III ThermoDox(R) Trial For Primary Liver Cancer
- $6.5 Million Gift To UCSF From Irwin And Joan Jacobs For Head And Neck Cancer Research
Random Posts
- VEGF Inhibitor Linked to GI Bleed (CME/CE)
- Sexually Transmitted HPV Linked To Certain Head & Neck Cancers; Roswell Park Cancer Institute Researchers Say Boys Need To Be Vaccinated Too
- In Quest For Gene Therapies, Junk DNA May Prove Invaluable
- Breast Cancer Risk Reduction Guide Adds Raloxifene (CME/CE)
- Collaborative Drug Discovery Partnership To Advance Cancer Drug Development
- No Benefit, Some Harm in SCLC with Thalidomide (CME/CE)
- Shedding Light On Inner Workings Of Human Embryonic Stem Cells
- Revealing Critical Link In Cell Death Pathway
- Women Lag Behind Men in Cancer Trial Representation (CME/CE)
- ASCO: Skin Regimen Cuts Chances of EGFR-Induced Rash (CME/CE)
Prescription Cancer Drugs
American Society Of Clinical Oncology (ASCO) Statement On Cuts To Cancer Care In 2010 Medicare Physician Fee Schedule
Posted by: admin in Prescription Cancer Drugs on November 03rd, 2009
Below is a statement for attribution to ASCO CEO Allen S. Lichter, MD:
“Today, CMS issued its physician fee schedule for 2010. The schedule included a one percent cut to oncology services in 2010, part of an overall six percent reduction in reimbursement for cancer care over the next four years. We are deeply concerned that these cuts will continue to erode access to cancer care in the United States.
“The cumulative effect of previous cuts has already caused oncologists to close practices, consolidate locations, and turn away Medicare patients. Further reductions will jeopardize access to care for more people with cancer across the country. Oncology cannot sustain additional cuts at a time when the number of people with cancer is increasing, practice expenses continue to rise, and the oncology workforce is dwindling.”
ASCO’s fee schedule fact sheet summarizes how cuts in Medicare coverage to date have already affected patient care, forcing physicians to close practices, consolidate locations, and turn away Medicare patients.
Source
American Society of Clinical Oncology
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.